3rd Annual Gene Therapy Analytical Development Summit 2021
Evvnt Promotion / evvnt
Archiv

29.11.2021 - 02.12.2021 Online
Time: 9:00 am - 4:00 pm
Kongressthemen
As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, the 3rd Annual Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products.
As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, the 3rd Annual Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/860175-3?pid=4832
Speakers: Arden Bond, Senior Scientist, AskBio, Hai Yue, Associate Scientific Director, Bristol Myers Squibb, Irnela Bajrovic, Formulation Scientist, Ask Bio and more
Brochure: https://go.evvnt.com/860175-3?pid=4832
Speakers: Arden Bond, Senior Scientist, AskBio, Hai Yue, Associate Scientific Director, Bristol Myers Squibb, Irnela Bajrovic, Formulation Scientist, Ask Bio and more
Anfragen und Anmeldung:
https://go.evvnt.com/860175-2?pid=4832
Frau Olivia Bull
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 2199.00 - USD 4297.00
USD 2199.00 - USD 4297.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."